Highly driven by interests of transforming science into state-of-the-art medical technologies and products with a belief to create social and commercial benefits on their own. I hold over 10 years of experience in business development/licensing, product development, and new product entrance strategy, as well as fundraising to fulfill corporate goal, most recently committed to innovative antibody drug and disruptive cellular and gene therapies with great unmet clinical needs.